Amy Chang

1.9k total citations · 1 hit paper
28 papers, 940 citations indexed

About

Amy Chang is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Amy Chang has authored 28 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Amy Chang's work include Head and Neck Cancer Studies (11 papers), Advanced Radiotherapy Techniques (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Amy Chang is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Advanced Radiotherapy Techniques (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Amy Chang collaborates with scholars based in China, Hong Kong and United States. Amy Chang's co-authors include Oscar S.H. Chan, Wai Tong Ng, Anne W.M. Lee, Rebecca M.W. Yeung, Michael C.H. Lee, Lucy Chan, Wai Man Hung, Henry Sze, Connie Chan and Albert W.M. Hung and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Human Reproduction.

In The Last Decade

Amy Chang

26 papers receiving 931 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era

2014 276 citations Anne W.M. Lee, Wai Tong Ng et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Amy Chang

Since Specialization

Citations

This map shows the geographic impact of Amy Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Chang more than expected).

Fields of papers citing papers by Amy Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Chang. The network helps show where Amy Chang may publish in the future.

Co-authorship network of co-authors of Amy Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Chang. A scholar is included among the top collaborators of Amy Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Chang. Amy Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1913P Five year results of transbronchial microwave ablation of lung malignancies with electromagnetic navigation guidance 2024 ·Annals of Oncology ·Judy Yuet‐Wa Chan, Amy Chang, (unknown), (unknown), Jenny Ngai, (unknown), (unknown), (unknown)	1
2	Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203 2023 ·Gynecologic Oncology ·André Konski, Snehal Deshmukh, Ann H. Klopp, Anamaria R. Yeung, Shannon N. Westin, J. S. Thompson, Desiree E. Doncals, Guilherme Cantuaria, David D’Souza, Amy Chang, Vijayananda Kundapur, Dasarahally S. Mohan, Michael L. Haas, Yong Bae Kim, C.L. Ferguson, Stephanie L. Pugh, Lisa A. Kachnic, Deborah Watkins Bruner	1
3	A Multi-Center Study of CT-Based Neck Nodal Radiomics for Predicting an Adaptive Radiotherapy Trigger of Ill-Fitted Thermoplastic Masks in Patients with Nasopharyngeal Carcinoma 2022 ·Life ·Saikit Lam, Jiang Zhang, Yuanpeng Zhang, Bing Li, (unknown), Ta Zhou, Tao Peng, (unknown), (unknown), (unknown), (unknown), Kwok‐Hung Au, Victor Lee, Amy Chang, Lawrence Chan, Jing Cai	14
4	Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy 2021 ·Annals of Translational Medicine ·Fang Chen, Hao Yu, Hong Zhang, (unknown), Qian Wang, (unknown), (unknown), Junjie Wu, Zheng Zhou, Yang Li, Zhiyuan Xu, Yaya Liu, Pingfu Fu, Jian‐Yue Jin, Victor Hsue, Amy Chang, Feng‐Ming Kong	17
5	Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy 2020 ·Open Forum Infectious Diseases ·Amy Chang, (unknown), Markian R. Bochan	2
6	ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI 2020 ·Lung Cancer ·Oscar S.H. Chan, Kwok Chi Lam, (unknown), (unknown), (unknown), Amy Chang, Frankie Mo, Ki Wang, Rebecca M.W. Yeung, Tony Mok	49
7	Knowledge-based planning in nasopharyngeal carcinoma 2020 ·Wai Man Hung, (unknown), Amy Chang, Michael C.H. Lee, Wai Tong Ng	1
8	3d Printing Technology is a Feasible and Efficient Tool for Pre-Planning for Image Guided Brachytherapy of Cervix Cancers 2018 ·Brachytherapy ·Amy Chang	1
9	The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis 2017 ·Clinical Oncology ·Oscar S.H. Chan, Victor Lee, Tony Mok, Frankie Mo, Amy Chang, Rebecca M.W. Yeung	51
10	Comparison of Planning Quality and Efficiency Between Conventional and Knowledge-based Algorithms in Nasopharyngeal Cancer Patients Using Intensity Modulated Radiation Therapy 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Amy Chang, Albert W.M. Hung, (unknown), Michael C.H. Lee, Oscar S.H. Chan, (unknown), (unknown), Wai Tong Ng	127
11	Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant 2015 ·Current Treatment Options in Oncology ·Wai Tong Ng, Amy Chang, (unknown), Henry Sze, Anne W.M. Lee	14
12	Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era breakdown → 2014 ·Radiotherapy and Oncology ·Anne W.M. Lee, Wai Tong Ng, Lucy Chan, Wai Man Hung, Connie Chan, Henry Sze, Oscar S.H. Chan, Amy Chang, Rebecca M.W. Yeung	276
13	Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4? 2014 ·Oral Oncology ·Henry Sze, Lucy Chan, Wai Tong Ng, Albert W.M. Hung, Michael C.H. Lee, Amy Chang, Oscar S.H. Chan, (unknown), Rebecca M.W. Yeung, Anne W.M. Lee	26
14	The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT 2014 ·Oral Oncology ·Wai Tong Ng, Michael C.H. Lee, Amy Chang, Oscar S.H. Chan, Lucy Chan, (unknown), Wai Man Hung, Connie Chan, Anne W.M. Lee	70
15	Adjuvant chemoradiation for resected gastric cancer: a 10-year experience 2011 ·Gastric Cancer ·Amy Chang, Wai Tong Ng, (unknown), (unknown), Michael C.H. Lee, Anne W.M. Lee	18
16	The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer – A planning study 2011 ·Radiotherapy and Oncology ·Oscar S.H. Chan, Michael C.H. Lee, Albert W.M. Hung, Amy Chang, Rebecca M.W. Yeung, Anne W.M. Lee	55
17	Major Late Toxicities After Conformal Radiotherapy for Nasopharyngeal Carcinoma—Patient- and Treatment-Related Risk Factors 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Anne W.M. Lee, Wai Tong Ng, (unknown), Cheuk‐Wai Choi, Raymond Tung, (unknown), (unknown), T.K. Yau, Amy Chang, Samuel Leung, Michael C.H. Lee, Søren M. Bentzen	76
18	Clinical Outcome of Breast Conservation Therapy for Breast Cancer in Hong Kong: Prognostic Impact of Ipsilateral Breast Tumor Recurrence and 2005 St. Gallen Risk Categories 2007 ·International Journal of Radiation OncologyBiologyPhysics ·T.K. Yau, Inda Soong, Ko Ling Chan, M Chan, Catherine S. K. Cheung, (unknown), Amy Chang, Anne W.M. Lee	10
19	Surveillance mammography after breast conservation therapy in Hong Kong: Effectiveness and feasibility of risk-adapted approach 2007 ·The Breast ·T.K. Yau, (unknown), Inda Soong, (unknown), Ko Ling Chan, Amy Chang, (unknown), (unknown)	6
20	Wide Local Excision and Radiotherapy for the Treatment of Ductal Carcinoma in situ of the Breast: the Hong Kong Experience 2006 ·Clinical Oncology ·T.K. Yau, Ko Ling Chan, M Chan, (unknown), Inda Soong, Catherine S. K. Cheung, Amy Chang, (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact